This introductory phase allows the body to adjust to GLP-1, GIP, and glucagon receptor activation simultaneously
These combined effects help to lower blood sugar levels and reduce appetite, leading to improved glycemic control and potential weight loss
"And we hope Lilly is the one presenting those choices."
Lillys currently approved injection, Zepbound, and Novo Nordisks Wegovy have shown weight loss of roughly 15% to 20% in different trials, according to Reuters, while Lillys oral obesity pill, Foundayo, has delivered about 11% weight loss
Alterra Health can help
Phase 2: Transition to Maintenance (Months 6-9) Once your weight has plateaued (typically around week 40-48 if you started escalation on schedule), it is time to find your maintenance dose